Noninvasive screening of ocular surface disease in otherwise healthy patients scheduled for cataract surgery

Abstract

Purpose To evaluate prevalence and characteristics of pathological ocular surface findings in healthy patients undergoing cataract surgery using a noninvasive ocular surface workup and a validated questionnaire. Design Prospective single-centre study (sub-analysis clinical trial no. NCT05754437). Methods Healthy patients undergoing senile cataract surgery were screened preoperatively by Oculus Keratograph (K5 M; Oculus GmbH, Wetzlar, Germany) for the evaluation of tear meniscus height (TMH), non-invasive keratograph break-up time (NIKBUT), and meibomian gland dropout. Ocular discomfort symptoms were scored by ocular surface disease index (OSDI) questionnaire. Results 120 eyes of 120 patients (62 females, 58 males; mean age 73.85 years, range 47–91 years) were included. All patients had at least 1 abnormal finding, while 19 (15.8%; 95% CI [0.09–0.22]) had alterations of all parameters. In detail, 39 patients (32.5%; 95% CI [0.24–0.41]) had pathological TMH (mean 0,15 mm [0.03 SD]), 102 (85%; 95% CI [0.79–0.91]) had pathological NIKBUT (mean 3.64 s [2.63 SD]), 117 (97.5%; 95% CI [0.95–1]) had some degree of gland dropout (mean 1.62 [0.70 SD]), 78 patients (65%; 95% CI [0.56–0.74]) had pathological OSDI scores (mean 28.63 [15.08 SD]). Using TFOS DEWS II criteria, 66 patients (55%; 95% CI [0.42–0.60]) resulted affected by dry eye. Conclusions This quick noninvasive screening documented the high prevalence of pathological ocular surface parameters in patients without risk factors or previous diagnosis of dry eye who are scheduled for cataract surgery.